Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 4
2004 2
2005 1
2006 6
2007 2
2008 3
2009 2
2010 1
2011 1
2012 1
2013 2
2014 1
2015 2
2016 1
2017 1
2018 4
2019 1
2020 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

37 results
Results by year
Filters applied: . Clear all
Page 1
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).
Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, Du Pasquier R, Enzinger C, Fertl E, Gass A, Gehring K, Gobbi C, Goebels N, Guger M, Haghikia A, Hartung HP, Heidenreich F, Hoffmann O, Kallmann B, Kleinschnitz C, Klotz L, Leussink VI, Leutmezer F, Limmroth V, Lünemann JD, Lutterotti A, Meuth SG, Meyding-Lamadé U, Platten M, Rieckmann P, Schmidt S, Tumani H, Weber F, Weber MS, Zettl UK, Ziemssen T, Zipp F; ‘Multiple Sclerosis Therapy Consensus Group’ (MSTCG). Wiendl H, et al. Among authors: czaplinski a. Ther Adv Neurol Disord. 2021 Aug 18;14:17562864211039648. doi: 10.1177/17562864211039648. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34422112 Free PMC article. Review.
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)].
Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Stangel M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, Du Pasquier R, Enzinger C, Fertl E, Gass A, Gehring K, Gobbi C, Goebels N, Guger M, Haghikia A, Hartung HP, Heidenreich F, Hoffmann O, Hunter ZR, Kallmann B, Kleinschnitz C, Klotz L, Leussink V, Leutmezer F, Limmroth V, Lünemann JD, Lutterotti A, Meuth SG, Meyding-Lamadé U, Platten M, Rieckmann P, Schmidt S, Tumani H, Weber MS, Weber F, Zettl UK, Ziemssen T, Zipp F; die Multiple Sklerose Therapie Konsensus Gruppe (MSTKG). Wiendl H, et al. Among authors: czaplinski a. Nervenarzt. 2021 Aug;92(8):773-801. doi: 10.1007/s00115-021-01157-2. Epub 2021 Jul 23. Nervenarzt. 2021. PMID: 34297142 Free PMC article. Review. German.
[Tic syndrome].
Czapliński A, Steck AJ, Fuhr P. Czapliński A, et al. Neurol Neurochir Pol. 2002 May-Jun;36(3):493-504. Neurol Neurochir Pol. 2002. PMID: 12185806 Review. Polish.
Stem cells for ALS: An overview of possible therapeutic approaches.
Czarzasta J, Habich A, Siwek T, Czapliński A, Maksymowicz W, Wojtkiewicz J. Czarzasta J, et al. Among authors: czaplinski a. Int J Dev Neurosci. 2017 Apr;57:46-55. doi: 10.1016/j.ijdevneu.2017.01.003. Epub 2017 Jan 11. Int J Dev Neurosci. 2017. PMID: 28088365 Review.
[Symptomatic management in amyotrophic lateral sclerosis (ALS)].
Czaplinski A, Schweikert K, Strobel W, Steck AJ, Weber M. Czaplinski A, et al. Praxis (Bern 1994). 2006 Feb 22;95(8):263-8, 269-71. doi: 10.1024/0369-8394.95.8.263. Praxis (Bern 1994). 2006. PMID: 16523990 Review. German.
Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional study.
Barin L, Kaufmann M, Salmen A, Kamm CP, Gobbi C, Kuhle J, Pot C, Chan A, Czaplinski A, Ajdacic-Gross V, Rodgers S, Kesselring J, Puhan MA, von Wyl V; Swiss Multiple Sclerosis Registry. Barin L, et al. Among authors: czaplinski a. Mult Scler Relat Disord. 2019 Feb;28:17-25. doi: 10.1016/j.msard.2018.11.033. Epub 2018 Dec 2. Mult Scler Relat Disord. 2019. PMID: 30530118
[Inclusion body myositis (IBM) -- a review].
Czaplinski A, Renaud S, Fuhr P. Czaplinski A, et al. Praxis (Bern 1994). 2003 Apr 2;92(14):649-54. doi: 10.1024/0369-8394.92.14.649. Praxis (Bern 1994). 2003. PMID: 12723314 Review. German.
37 results